KA6-20524-45607
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 801 / CO
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · HeadacheFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-09
- 2021-05-21
- 2021-05-30
- 2021-06-06
- 2021-07-23
- 2021-10-24
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-07
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Pregnancy — Feeling: Good · Fatigue or tirednessFree text: I just found out I'm pregnant.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-14
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
-
2022-02-04
Survey response — 3 months, dose 3MedDRA: Conjunctivitis, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Pink eye, sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-10
Call successfulDoes not wish to fill out VAERS report
- 2022-05-06
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): I just found out I'm pregnant.
Release 11 — 3 months, dose 3
Symptoms: Pink eye, sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release